These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Two-dimensional gel electrophoresis of ribosomal proteins from Propionibacterium acnes and granulosum. Dekio S, Hashimoto K, Makino M. Zentralbl Bakteriol; 1989 Oct; 271(4):442-51. PubMed ID: 2818796 [Abstract] [Full Text] [Related]
28. Differential susceptibility of Propionibacterium acnes, P. granulosum and P. avidum to free fatty acids. Ko HL, Heczko PB, Pulverer G. J Invest Dermatol; 1978 Dec; 71(6):363-5. PubMed ID: 722112 [Abstract] [Full Text] [Related]
30. Suppression of cell-mediated tumour immunity by Corynebacterium parvum. Kirchner H, Glaser M, Herberman R. Nature; 1975 Oct 02; 257(5525):396-8. PubMed ID: 170531 [No Abstract] [Full Text] [Related]
31. [Differentiation of various Propionibacterium species from acne-vulgaris efflorescences]. Lentze I, Ko HL, Höffler U. Hautarzt; 1979 May 02; 30(5):242-7. PubMed ID: 156167 [Abstract] [Full Text] [Related]
33. The effect of C. parvum therapy on intratumoral macrophage subpopulations. McBride WH, Moore K. Adv Exp Med Biol; 1982 May 02; 155():731-6. PubMed ID: 7158508 [No Abstract] [Full Text] [Related]
40. Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum. Milas L, Gutterman JU, Basic I, Hunter N, Mavligit GM, Hersh EM, Withers HR. Int J Cancer; 1974 Oct 15; 14(4):493-503. PubMed ID: 4459276 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]